97 related articles for article (PubMed ID: 15010129)
21. Nanostructured microspheres produced by supercritical fluid extraction of emulsions.
Della Porta G; Reverchon E
Biotechnol Bioeng; 2008 Aug; 100(5):1020-33. PubMed ID: 18383122
[TBL] [Abstract][Full Text] [Related]
22. Controlled release of bioactive doxorubicin from microspheres embedded within gelatin scaffolds.
Defail AJ; Edington HD; Matthews S; Lee WC; Marra KG
J Biomed Mater Res A; 2006 Dec; 79(4):954-62. PubMed ID: 16941588
[TBL] [Abstract][Full Text] [Related]
23. Nano/micro technologies for delivering macromolecular therapeutics using poly(D,L-lactide-co-glycolide) and its derivatives.
Mundargi RC; Babu VR; Rangaswamy V; Patel P; Aminabhavi TM
J Control Release; 2008 Feb; 125(3):193-209. PubMed ID: 18083265
[TBL] [Abstract][Full Text] [Related]
24. [New approaches for encapsulation of peptides into poly(lactic/glycolic acid) microspheres].
Blanco-Prieto MJ; Fattal E; Puisieux F; Couvreur P
Ann Pharm Fr; 1998; 56(6):256-63. PubMed ID: 9872012
[TBL] [Abstract][Full Text] [Related]
25. A novel trans-lymphatic drug delivery system: implantable gelatin sponge impregnated with PLGA-paclitaxel microspheres.
Liu J; Meisner D; Kwong E; Wu XY; Johnston MR
Biomaterials; 2007 Jul; 28(21):3236-44. PubMed ID: 17434581
[TBL] [Abstract][Full Text] [Related]
26. The effect of freeze-drying with different cryoprotectants and gamma-irradiation sterilization on the characteristics of ciprofloxacin HCl-loaded poly(D,L-lactide-glycolide) nanoparticles.
Bozdag S; Dillen K; Vandervoort J; Ludwig A
J Pharm Pharmacol; 2005 Jun; 57(6):699-707. PubMed ID: 15969924
[TBL] [Abstract][Full Text] [Related]
27. Ammonolysis-based microencapsulation technique using isopropyl formate as dispersed solvent.
Im HY; Sah H
Int J Pharm; 2009 Dec; 382(1-2):130-8. PubMed ID: 19715744
[TBL] [Abstract][Full Text] [Related]
28. Effect of polyethylene glycol on preparation of rifampicin-loaded PLGA microspheres with membrane emulsification technique.
Ito F; Fujimori H; Honnami H; Kawakami H; Kanamura K; Makino K
Colloids Surf B Biointerfaces; 2008 Oct; 66(1):65-70. PubMed ID: 18585903
[TBL] [Abstract][Full Text] [Related]
29. Gentamicin-loaded discs and microspheres and their modifications: characterization and in vitro release.
Naraharisetti PK; Lew MD; Fu YC; Lee DJ; Wang CH
J Control Release; 2005 Feb; 102(2):345-59. PubMed ID: 15653156
[TBL] [Abstract][Full Text] [Related]
30. Preparation and characterization of PLGA particles for subcutaneous controlled drug release by membrane emulsification.
Gasparini G; Kosvintsev SR; Stillwell MT; Holdich RG
Colloids Surf B Biointerfaces; 2008 Feb; 61(2):199-207. PubMed ID: 17919891
[TBL] [Abstract][Full Text] [Related]
31. Influence of post-emulsification drying processes on the microencapsulation of human serum albumin.
Lane ME; Brennan FS; Corrigan OI
Int J Pharm; 2006 Jan; 307(1):16-22. PubMed ID: 16274944
[TBL] [Abstract][Full Text] [Related]
32. Encapsulation and release characteristics of DCTN/PLGA microspheres.
Morais WA; Costa MP; Paixão AD; Maciel MA; Santos-Magalhães NS
J Microencapsul; 2009 Sep; 26(6):529-34. PubMed ID: 18855199
[TBL] [Abstract][Full Text] [Related]
33. Versatility of biodegradable poly(D,L-lactic-co-glycolic acid) microspheres for plasmid DNA delivery.
Díez S; Tros de Ilarduya C
Eur J Pharm Biopharm; 2006 Jun; 63(2):188-97. PubMed ID: 16697172
[TBL] [Abstract][Full Text] [Related]
34. Stability of bovine serum albumin complexed with PEG-poly(L-histidine) diblock copolymer in PLGA microspheres.
Kim JH; Taluja A; Knutson K; Han Bae Y
J Control Release; 2005 Dec; 109(1-3):86-100. PubMed ID: 16266769
[TBL] [Abstract][Full Text] [Related]
35. Effect of mean diameter and polydispersity of PLG microspheres on drug release: experiment and theory.
Berchane NS; Carson KH; Rice-Ficht AC; Andrews MJ
Int J Pharm; 2007 Jun; 337(1-2):118-26. PubMed ID: 17289316
[TBL] [Abstract][Full Text] [Related]
36. Ammonolysis-induced solvent removal: a facile approach for solidifying emulsion droplets into PLGA microspheres.
Kim J; Hong D; Chung Y; Sah H
Biomacromolecules; 2007 Dec; 8(12):3900-7. PubMed ID: 18031011
[TBL] [Abstract][Full Text] [Related]
37. Polyelectrolyte complex of chondroitin sulfate and peptide with lower pI value in poly(lactide-co-glycolide) microsphere for stability and controlled release.
Park W; Na K
Colloids Surf B Biointerfaces; 2009 Sep; 72(2):193-200. PubMed ID: 19414243
[TBL] [Abstract][Full Text] [Related]
38. Optimization of prednisolone acetate-loaded chitosan microspheres using a 2(3) factorial design for preventing restenosis.
Sarisözen C; Arica B; Orman MN; Hincal AA; Caliş S
Drug Deliv; 2010 Apr; 17(3):178-86. PubMed ID: 20196705
[TBL] [Abstract][Full Text] [Related]
39. PLGA/mesoporous silica hybrid structure for controlled drug release.
Xue JM; Shi M
J Control Release; 2004 Aug; 98(2):209-17. PubMed ID: 15262413
[TBL] [Abstract][Full Text] [Related]
40. Factors affecting the loading efficiency of water-soluble drugs in PLGA microspheres.
Ito F; Fujimori H; Makino K
Colloids Surf B Biointerfaces; 2008 Jan; 61(1):25-9. PubMed ID: 17719753
[TBL] [Abstract][Full Text] [Related]
[Previous] [Next] [New Search]